|
|
Study on Preparation and Properties of Immune Adsorbent for Rheumatoid Factorremoval in Hemoperfusion |
1 Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering College, Chongqing University,Chongqing 400044, China
2 Third Military Medical University, The First Affiliated Hospital, Integrated Traditional Chinese and Western Medicine, Department of Rheumatology Centre, Chongqing 400038, China |
|
|
Abstract In this work we prepared an adsorbent (PS-PHE) aiming to remove rheumatoid factors and studied its performance. In the PSPHE, the chloromethyl resin acted as carrier grafting with the linker of heparin, to which phenylalanine was connected. The adsorption rate of adsorbent was investigated by in vitro RF dynamic perfusion. We conducted in vitro elution experiment to measure the abscission rate of RF. Selectivity of adsorbent was evaluated by blood components before and after perfusion. The prothrombin time (PTs) and thrombin time (TTs) detection in vitro verify the blood compatibility of adsorbent. The adsorption equilibrium was reached in less than two hours, and 90% of the maximum adsorption capacity was reached only under 1 hour, while the adsorption rate of IgA RF, IgG RF and IgM RF in serum was 45.21%±1.80%、56.02%±1.36%、52.40%±2.01% (n=5). After elution, the abscission rate of IgA RF, IgG RF and IgM RF was 22.10%±1.65%、19.23%±1.06%、21.31%±1.35% (n=5). After perfusion experiment, the variation rates of albumen and red blood cell were both less than 10%. The detection results of PTs and TTs showed PS-PHE delayed the coagulation rate. In conclusion, PS-PHE has higher absorption rate to RF and good blood compatibility, showing good application prospects.
|
|
|
|
|
[1]Hong J, Xu D, Gong P, et al. Covalent binding of αchymotrypsin on the magneticnanogels covered by amino groups[J]. Journal of Molecular Catalysis B: Enzymatic, 2007, 45(3): 84-90.
[2]Yamazaki Z, Fujimori Y, Takahama T, et al. Efficiency and biocompatibility of a new immunosorbent[J]. ASAIO Journal, 1982, 28: 318&hyhen.
[3]Kolb G. Rapid Adsorption of Rheumatoid Factor (RF) on Suspension of GlutaraidehydeCrosslinked Immunoglobulin G (IGG)A Method to Avoid RF Interference[J]. Artificial Cells, Blood Substitutes and Biotechnology, 1990, 18(5): 605-616.
[4]Ren J, Jia L, Xu L, et al. Removal of autoantibodies by 4-mercaptoethylpyridinebased adsorbent [J]. Journal of Chromatography B, 2009, 877(11): 1200-1204.
[5]唐金龙.肝素化改性大孔树脂对人低密度脂蛋白选择性吸附的研究[D]. 重庆大学,2012.
[6]王菲菲. 一种新型内毒素特异吸附的血液净化材料的制备与性能研究[D].重庆大学, 2012.
[7]靳欣欣,王翔,毛金春, 等. 肝素连接苯丙氨酸血液净化材料去除内毒素的研究[J].中国生物医学工程学报,2013, 32(3): 348-355.
[8]Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH[J]. Therapeutic Apheresis and Dialysis, 2003, 7(1): 85-90.
[9]Sutton B, Corper A, Bonagura V, et al. The structure and origin of rheumatoid factors[J]. Immunology today, 2000, 21(4): 177-183.
[10]Marijn ED, Thermo scientific product manual: NHS and sulfoNHS.
[11]Smith PK, Mallia AK, Hermanson GT. Colorimetric method for the assay of heparin content in immobilized heparin preparations[J]. Analytical Biochemistry, 1980, 109(2): 466-473.
[12]俞耀庭,张兴栋. 生物医用材料[M]. 天津: 天津大学出版社, 2000.
[13]张晓晓, 魏荣卿,刘晓宁,等.氯乙酰化聚苯乙烯树脂的胺基化反应[J]. 化工进展, 2008, 27(5): 715-719.
[14]奚廷斐. 生物材料血液相容性评价方法的研究[J]. 生物医学工程学杂志, 1987, 4(1): 42-48.
|
|
|
|